Top Markets
#1 OriginTrail OriginTrail +34.00%
#2 Tutorial Tutorial +12.08%
#3 MarsCoin MarsCoin +11.70%
#4 Waves Waves +10.84%
#5 Pons Pons +8.58%
#6 Siren Siren +8.36%
#7 Synapse Synapse +7.21%
#8 Cortex Cortex +7.15%
#9 Euler Euler +6.25%
#10 TROLL TROLL +6.08%
Coin of the day
OriginTrail OriginTrail
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
Classement en actions #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Prix de l'action
$0.49606484
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$88.47M
Changement (1 jour)
-1.58%
Changement (1 an)
-22.51%
Pays
TW
Échange Intech Biopharm Corporation (6461)

Catégorie

Healthcare
Ratio P/S pour Intech Biopharm Corporation (6461)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Intech Biopharm Corporation, le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Intech Biopharm Corporation de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH